18 Prediction of Immune-Related Adverse Events (irAEs) with Hematologic Markers in Patients Receiving First-Line Immune Checkpoint Inhibitor (ICI)-Based Therapy in Metastatic Renal Cell Carcinoma (mRCC) - Rahul Winayak; Xiaochen Li; Vitor Abreu de Góes; Ali Moradi; Salvador Jaime Casas; Koral Shah; Nicholas Salgia; Benjamin Mercier; Michelle Li; Jadon Fann; George Zhang; Ruchi Agarwal; et al. (The Oncologist, 2026)